1. Home
  2. JQC vs FTRE Comparison

JQC vs FTRE Comparison

Compare JQC & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JQC
  • FTRE
  • Stock Information
  • Founded
  • JQC 2003
  • FTRE 1996
  • Country
  • JQC United States
  • FTRE United States
  • Employees
  • JQC N/A
  • FTRE N/A
  • Industry
  • JQC Finance Companies
  • FTRE Medical Specialities
  • Sector
  • JQC Finance
  • FTRE Health Care
  • Exchange
  • JQC Nasdaq
  • FTRE Nasdaq
  • Market Cap
  • JQC 753.9M
  • FTRE 864.4M
  • IPO Year
  • JQC N/A
  • FTRE N/A
  • Fundamental
  • Price
  • JQC $5.06
  • FTRE $12.72
  • Analyst Decision
  • JQC
  • FTRE Hold
  • Analyst Count
  • JQC 0
  • FTRE 8
  • Target Price
  • JQC N/A
  • FTRE $11.64
  • AVG Volume (30 Days)
  • JQC 714.6K
  • FTRE 1.4M
  • Earning Date
  • JQC 01-01-0001
  • FTRE 11-05-2025
  • Dividend Yield
  • JQC 11.13%
  • FTRE N/A
  • EPS Growth
  • JQC N/A
  • FTRE N/A
  • EPS
  • JQC N/A
  • FTRE N/A
  • Revenue
  • JQC N/A
  • FTRE $2,759,900,000.00
  • Revenue This Year
  • JQC N/A
  • FTRE $0.47
  • Revenue Next Year
  • JQC N/A
  • FTRE N/A
  • P/E Ratio
  • JQC N/A
  • FTRE N/A
  • Revenue Growth
  • JQC N/A
  • FTRE 1.88
  • 52 Week Low
  • JQC $4.82
  • FTRE $3.97
  • 52 Week High
  • JQC $5.65
  • FTRE $25.05
  • Technical
  • Relative Strength Index (RSI)
  • JQC 46.48
  • FTRE 64.57
  • Support Level
  • JQC $5.08
  • FTRE $9.87
  • Resistance Level
  • JQC $5.00
  • FTRE $10.70
  • Average True Range (ATR)
  • JQC 0.04
  • FTRE 1.00
  • MACD
  • JQC 0.00
  • FTRE 0.12
  • Stochastic Oscillator
  • JQC 57.89
  • FTRE 81.17

About JQC Nuveen Credit Strategies Income Fund Shares of Beneficial Interest

Nuveen Credit Strategies Income Fund is a diversified closed-end management investment company. Its investment objective is to provide high current income and total return. The fund meets its investment objectives by investing its managed assets in senior secured and second lien loans, and its managed assets across the capital structure of companies (including equity securities) with a primary emphasis on high yield bonds, convertible securities and other forms of income-producing securities.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: